Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Antihypertenseur And NotNathalie Tzourio-Mazoyer

List of bibliographic references

Number of relevant bibliographic references: 56.
Ident.Authors (with country if any)Title
000056 J. J. Brugts [Pays-Bas] ; Hisatomi Arima [Australie] ; W. Remme [Pays-Bas] ; M. Bertrand [France] ; R. Ferrari [Italie] ; K. Fox [Royaume-Uni] ; J. Dinicolantonio [États-Unis] ; S. Macmahon [Australie] ; J. Chalmers [Australie] ; F. Zijlstra [Pays-Bas] ; K. Caliskan [Pays-Bas] ; M. L. Simoons [Pays-Bas] ; J. J. Mourad [France] ; E. Boersma [Pays-Bas] ; K. M. Akkerhuis [Pays-Bas]The incidence and clinical predictors of ACE-inhibitor induced dry cough by perindopril in 27,492 patients with vascular disease
000692 Craig S. Anderson [Australie] ; Emma Heeley [Australie] ; YINING HUANG [République populaire de Chine] ; JIGUANG WANG [République populaire de Chine] ; Christian Stapf [France] ; Candice Delcourt [Australie] ; Richard Lindley [Australie] ; Thompson Robinson [Royaume-Uni] ; Pablo Lavados [Chili] ; Bruce Neal [Australie] ; Jun Hata [Australie, Japon] ; Hisatomi Arima [Australie] ; Mark Parsons [Australie] ; YUECHUN LI ; JINCHAO WANG [République populaire de Chine] ; Stephane Heritier [Australie] ; QIANG LI [Australie] ; Mark Woodward [Australie, États-Unis] ; R. John Simes [Australie] ; Stephen M. Davis [Australie] ; John Chalmers [Australie]Rapid Blood-Pressure Lowering in Patients with Acute Intracerebral Hemorrhage
001161 Jennifer K. Rogers [Royaume-Uni] ; John J. V. Mcmurray [Royaume-Uni] ; Stuart J. Pocock [Royaume-Uni] ; Faiez Zannad [France] ; Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Karl Swedberg [Suède] ; Harry Shi [États-Unis] ; John Vincent [États-Unis] ; Bertram Pitt [États-Unis]Eplerenone in Patients With Systolic Heart Failure and Mild Symptoms: Analysis of Repeat Hospitalizations
001179 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie, Royaume-Uni] ; Giuseppe Mancia [Italie] ; Marie-Germaine Bousser [France] ; Christophe Tzourio [France] ; Anthony Rodgers [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Blood Pressure Lowering on Intracranial and Extracranial Bleeding in Patients on Antithrombotic Therapy: The PROGRESS Trial
001B22 Faiez Zannad [France] ; John J. V. Mcmurray [Royaume-Uni] ; Henry Krum [Australie] ; Dirkj. Van Veldhuisen [Pays-Bas] ; Karl Swedberg [Suède] ; Harry Shi [États-Unis] ; John Vincent [États-Unis] ; Stuartj. Pocock [États-Unis] ; Bertram Pitt [États-Unis]Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms
001B55 Henry Krum [Australie] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Christian Funck-Brentano [France] ; Emilio Vanoli [Italie] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Piotr Ponikowski [Pologne] ; Michael Goulder [Royaume-Uni] ; Wilfried Meyer [Allemagne] ; Philippe Lechat [France] ; Ronnie Willenheimer [Suède]Effect on Mode of Death of Heart Failure Treatment Started with Bisoprolol Followed by Enalapril, Compared to the Opposite Order: Results of the Randomized CIBIS III Trial
002087 Shima Mehrabian [France, Bulgarie] ; Emmanuelle Duron [France] ; Florian Labouree [France] ; Florence Rollot [France] ; Alex Bune [Australie] ; Latchezar Traykov [Bulgarie] ; Olivier Hanon [France]Relationship between orthostatic hypotension and cognitive impairment in the elderly
002158 Hisatomi Arima [Australie] ; Craig Anderson [Australie] ; Teruo Omae [Japon] ; LISHENG LIU [République populaire de Chine] ; Christophe Tzourio [France] ; Mark Woodward [États-Unis] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Anthony Rodgers [Australie] ; John Chalmers [Australie]Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
002339 Sébastien Czernichow [Australie, France] ; Toshiharu Ninomiya [Australie] ; Rachel Huxley [Australie] ; André-Pascal Kengne [Australie] ; G. David Batty [Australie, Royaume-Uni] ; Diederick E. Grobbee [Pays-Bas] ; Mark Woodward [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Impact of Blood Pressure Lowering on Cardiovascular Outcomes in Normal Weight, Overweight, and Obese Individuals: The Perindopril Protection Against Recurrent Stroke Study Trial
002461 Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Craig Anderson [Australie] ; Mark Woodward [États-Unis] ; Marie-Germaine Bousser [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; John Chalmers [Australie]Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
002C37 Sophia Zoungas [Australie] ; Bastiaan E. De Galan [Australie, Pays-Bas] ; Toshiharu Ninomiya [Australie] ; Diederick Grobbee [Pays-Bas] ; Pavel Hamet [Canada] ; Simon Heller [Royaume-Uni] ; Stephen Macmahon [Australie] ; Michel Marre [France] ; Bruce Neal [Australie] ; Anushka Patel [Australie] ; Mark Woodward [Australie, États-Unis] ; John Chalmers [Australie]Combined Effects of Routine Blood Pressure Lowering and Intensive Glucose Control on Macrovascular and Microvascular Outcomes in Patients With Type 2 Diabetes: New results from the ADVANCE trial
002C57 Claude Julien [France] ; Sandra L. Burke [Australie] ; Geoffrey A. Head [Australie]Cardiac and renal baroreflex control during stress in conscious renovascular hypertensive rabbits : effect of rilmenidine. Commentary
003185 Luis M. Ruilope [Espagne] ; Bertram Pitt [États-Unis] ; Ali Ahmed [États-Unis] ; Thomas E. Love [États-Unis] ; Henry Krum [Australie] ; Jose Nicolau [Brésil] ; José S. Cardoso [Portugal] ; Alexander Parkhomenko [Ukraine] ; Michael Aschermann [République tchèque] ; Ramon Corbalan [Chili] ; Henry Solomon [États-Unis] ; Harry Shi [États-Unis] ; Faiez Zannad [France]History of Hypertension and Eplerenone in Patients With Acute Myocardial Infarction Complicated by Heart Failure. Commentary
003368 Emil Toader [France] ; Andrei Cividjian [France] ; Nicolas Rentero [France] ; Robin M. Mcallen [Australie] ; Luc Quintin [France]Cardioinhibitory actions of clonidine assessed by cardiac vagal motoneuron recordings
003A22 Enrico Agabiti-Rosei [Italie] ; Giuseppe Mancia [Italie] ; Michael F. O'Rourke [Australie] ; Mary J. Roman [États-Unis] ; Michel E. Safar [France] ; Harold Smulyan [États-Unis] ; Ji-Guang Wang [République populaire de Chine] ; Ian B. Wilkinson [Royaume-Uni] ; Bryan Williams [Royaume-Uni] ; Charalambos Vlachopoulos [Grèce]Central blood pressure measurements and antihypertensive therapy : A consensus document
003D32 Olivier Hanon [France] ; Renaud Pequignot [France] ; Marie Laure Seux [France] ; Hermine Lenoir [France] ; Alexandra Bune [Australie] ; Anne Sophie Rigaud [France] ; Francoise Forette [France] ; Xavier Girerd [France]Relationship between antihypertensive drug therapy and cognitive function in elderly hypertensive patients with memory complaints
003D54 Hisatomi Arima [Australie] ; Christophe Tzourio [France] ; Ken Butcher [Australie] ; Craig Anderson [Australie] ; Marie-Germaine Bousser [France] ; Kennedy R. Lees [Royaume-Uni] ; John L. Reid [Royaume-Uni] ; Teruo Omae [Japon] ; Mark Woodward [Australie] ; Stephen Macmahon [Australie] ; John Chalmers [Australie]Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial
003D55 F. Zannad [France] ; M. Kessler [France] ; P. Lehert [Australie, Belgique] ; J. P. Grünfeld [France] ; C. Thuilliez [France] ; A. Leizorovicz [France] ; P. Lechat [France]Prevention of cardiovascular events in end-stage renal disease : Results of a randomized trial of fosinopril and implications for future studies
003F04 Hisatomi Arima [Australie] ; John Chalmers [Australie] ; Mark Woodward [Australie] ; Craig Anderson [Australie] ; Anthony Rodgers [Nouvelle-Zélande] ; Stephen Davis [Australie] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie]Lower target blood pressures are safe and effective for the prevention of recurrent stroke : the PROGRESS trial
004642 Ronnie Willenheimer [Suède] ; Dirk J. Van Veldhuisen [Pays-Bas] ; Bernard Silke [Irlande (pays)] ; Erland Erdmann [Allemagne] ; Ferenc Follath [Suisse] ; Henry Krum [Australie] ; Piotr Ponikowski [Pologne] ; Allan Skene [Royaume-Uni] ; Louis Van De Ven [Allemagne] ; Patricia Verkenne [Allemagne] ; Philippe Lechat [France]Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence : Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III
004947 Nicola De Luca [Italie] ; Roland G. Asmar [France] ; Gérard M. London [France] ; Michael F. O'Rourke [Australie] ; Michel E. Safare [France]Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects
004A68 Gérard M. London [France] ; Roland G. Asmar [France] ; Michaël F. O'Rourke [Australie] ; Michel E. Safar [France]Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol
004B06 Jean L. Rouleau [Canada] ; Ellen B. Roecker [États-Unis] ; Michal Tendera [Pologne] ; Paul Mohacsi [Suisse] ; Henry Krum [Australie] ; Hugo A. Katus [Allemagne] ; Michael B. Fowler [États-Unis] ; Andrew J. S. Coats [Australie] ; Alain Castaigne [France] ; Armin Scherhag [Suisse] ; Terly L. Holcslaw [États-Unis] ; Milton Packer [États-Unis] ; Jay N. Cohn [États-Unis]Influence of pretreatment systolic blood pressure on the effect of Carvedilol in patients with severe chronic heart failure: The Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Author's reply
004B73 N. Chapman [Royaume-Uni] ; R. Huxley [Australie] ; C. Anderson [Nouvelle-Zélande] ; M. G. Bousser [France] ; J. Chalmers [Australie] ; S. Colman [Australie] ; S. Davis [Australie] ; G. Donnan [Australie] ; S. Macmahon [Australie] ; B. Neal [Australie] ; C. Warlow [Royaume-Uni] ; M. Woodward [Australie]Effects of a perindopril-based blood pressure-lowering regimen on the risk of Recurrent Stroke according to Stroke subtype and medical history: The PROGRESS trial
004B74 Duncan J. Campbell [Australie] ; Theodora Alexiou [Australie] ; Hong D. Xiao [Australie] ; Sebastien Fuchs [Australie] ; Michael J. Mckinley [Australie] ; Pierre Corvol [France] ; Kenneth E. Bernstein [Australie]Effect of reduced angiotensin-converting enzyme gene expression and angiotensin-converting enzyme inhibition on angiotensin and bradykinin peptide levels in mice
004D28 John Chalmers [Australie]Etude ADVANCE: objectifs, protocole et état actuel
004D83 Stephen B. Harrap [Australie] ; Christophe Tzourio [France] ; Francois Cambien [France] ; Odette Poirier [France] ; Segolene Raoux [France] ; John Chalmers [Australie] ; Neil Chapman [Australie] ; Samuel Colman [Australie] ; Solenn Leguennec [France] ; Stephen Macmahon [Australie] ; Bruce Neal [Australie] ; Takayoshi Ohkubo [Australie] ; Mark Woodward [Australie]The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition
005478 John B. Kostis [États-Unis] ; Stuart Cobbe [Royaume-Uni] ; Colin Johnston [Australie] ; Ian Ford [Royaume-Uni] ; Michael Murphy [Irlande (pays)] ; Michael A. Weber [États-Unis] ; Henry R. Black [France] ; Pierre Francois Plouin [France] ; Daniel Levy [États-Unis] ; Guiseppe Mancia [Italie] ; Pierre Larochelle [Canada] ; Rainer E. Kolloch [Allemagne] ; Michael Alderman [États-Unis] ; Luis Miguel Ruilope [Espagne] ; Björn Dahlöf [Suède] ; John M. Flack [États-Unis] ; Robert Wolf [États-Unis]Design of the Omapatrilat in Persons with Enhanced Risk of atherosclerotic events (OPERA) trial
005508 Stéphane Laurent [France] ; Bronwyn Kingwell [Australie] ; Alan Bank [États-Unis] ; Michael Weber [États-Unis] ; Harry Struijker-Boudier [Pays-Bas]Clinical applications of arterial stiffness: Therapeutics and pharmacology
005833 Roland G. Asmar [France] ; Gérard M. London [France] ; Michael E. O'Rourke [Australie] ; Michel E. Safar [France]Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patient: A comparison with atenolol
005C54 Pascal Bousquet [France] ; Monique Dontenwill [France] ; Hugues Greney [France] ; Josiane Feldman [France]Imidazoline receptors in cardiovascular and metabolic diseases
006016 JIN BO SU [France] ; F. Barbe [France] ; B. Crozatier [France] ; D. J. Campbell [Australie] ; L. Hittinger [France]Increased bradykinin levels accompany the hemodynamic response to acute inhibition of angiotensin-converting enzyme in dogs with heart failure
006065 A. Castaigne [France] ; J. Chalmers [Australie] ; T. Morgan [Australie] ; C. Chastang [France] ; L. Feldmann [France] ; D. Guez [France]Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamide 0.625 mg combination : A randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension
006216 T. Morgan [Australie] ; J. Menard [France] ; H. Brunner [Suisse]Twenty-four hour blood pressure control and trough to peak ratio : who, when, how and why? : Trough to peak ratios
006218 T. Morgan [Australie] ; J. Menard [France] ; H. Brunner [Suisse]Trough to peak ratio as a guide to BP control: measurement and calculation : Trough to peak ratios
006384 R. M. Schaefer [Allemagne] ; P. M. Aldons ; E. D. Burgess ; R. Tilvis [Finlande] ; X. Girerd [France] ; G. P. Singh [Nouvelle-Zélande] ; L. Rehn ; T. O. Morgan [Australie]Improved tolerability of felodipine compared with amlodipine in elderly hypertensives : A randomised, double-blind study in 535 patients, focusing on vasodilatory adverse events
006442 J. Feldman [France] ; H. Greney [France] ; L. Monassier [France] ; C. Vonthron [France] ; V. Bruban [France] ; M. Dontenwill [France] ; P. Bousquet [France]Does a second generation of centrally acting antihypertensive drugs really exist?
006609 J. Menard [France] ; D. J. Campbell [Australie] ; M. Azizi [France] ; M.-F. Gonzales [France]Synergistic effects of ACE inhibition and Ang II antagonism on blood pressure, cardiac weight, and renin in spontaneously hypertensive rats
006834
006B04 R. W. Sanson-Fisher [Australie] ; K. CloverCompliance in the treatment of hypertension : a need for action
006B94 L. Hansson [Suède]The place of β-blockers in the treatment of hypertension in 1993
006B95 C. I. Johnston [Australie]The place of diuretics in the treatment of hypertension in 1993 : can we do better ?
006B96 J. Chalmers [Australie]The place of combination therapy in the treatment of hypertension in 1993
006B97 J. L. Reid [Royaume-Uni]The place of alpha blockers in the treatment of hypertension
006C38 P. A. Van Zwieten [Pays-Bas]New avenues in antihypertensive drug treatment
006C47 A. F. Lever [Royaume-Uni] ; P. J. BrennanMRC trial of treatment in elderly hypertensives
006C65 P. K. Whelton [États-Unis] ; F. BrancatiHypertension management in populations
006C70 L. A. Salako [Nigeria]Hypertension in Africa and effectiveness of its management with various classes of antihypertensive drugs and in different socio-economic and cultural environments
006C90 C. J. Bulpitt [Royaume-Uni] ; A. E. FletcherCost-effectiveness of the treatment of hypertension
006C94 A. F. Schaub [Suisse] ; A. Steiner ; W. VetterCompliance to treatment
006C96 J. A. Cutler [États-Unis]Combinations of lifestyle modification and drug treatment in management of mild-moderate hypertension : a review of randomized clinical trials
006D01 F. C. Luft [Allemagne] ; H. HallerCalcium channel blockers in current medical practice : an update for 1993
006D08 L. Thijs [Belgique] ; A. Amery ; R. Antikainen ; P. Bert ; W. Birkenh Ger ; C. J. Bulpitt ; C. T. Dollery ; A. E. Fletcher ; F. Forette ; T. Hakam Ki ; P. Kivinen ; E. Lehtomaki ; E. O'Brien ; C. Sarti ; J. Staessen ; R. Tilvis ; B. Trimarco ; J. Tuomilehto ; H. Vanhanen ; O. V Nska ; J. Webster ; Y. YodfatAntihypertensive therapy in elderly patients with isolated systolic hypertension : third progress report of the syst-eur trial
006D10 J. L. Rodicio [Espagne] ; L. M. RuilopeAngiotensin-converting enzyme inhibitors in the treatment of mild arterial hypertension
006D11 H. R. Brunner [Suisse] ; J. Nussberger ; M. Burnier ; B. WaeberAngiotensin II antagonists
006D20

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024